Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced positive top-line data from a Phase 1 clinical trial of its Ebola virus glycoprotein (GP) recombinant nanoparticle vaccine candidate adjuvanted with Matrix-M™ as part of the World Health Organization’s (WHO) Fifth Teleconference on Ebola Vaccine Clinical Trials.
Cerulean Pharma Inc. today announced that the first patient has been dosed in an open label Phase 1b clinical trial of its lead product candidate, CRLX101, in combination with weekly paclitaxel in patients with relapsed ovarian cancer by the University of Virginia School of Medicine. This trial is being conducted by Cerulean in collaboration with the GOG Foundation under the direction of principal investigator, Carolyn N. Krasner, M.D., of the Massachusetts General Hospital Cancer Center.
ProPlus Design Solutions, Inc. today announced that eSilicon Corporation, a leading independent semiconductor design and manufacturing solutions provider, has selected its high-performance parallel SPICE simulator and its variation analysis platform for advanced intellectual property (IP) designs at 28-nanometer (nm), 16nm and beyond.
Industrial Nanotech, Inc., a global leader in nanotechnology based energy saving solutions, today announced that the Company has developed an ultra thin high performance thermal insulation film called MicroProtect™ for use on the interior of personal electronic devices including laptop computers and cellular phones.
Many human-made pollutants in the environment resist degradation through natural processes, and disrupt hormonal and other systems in mammals and other animals. Removing these toxic materials — which include pesticides and endocrine disruptors such as bisphenol A (BPA) — with existing methods is often expensive and time-consuming.
Nano-C, Inc. received clearance from the U.S. Environmental Protection Agency (EPA) to manufacture and sell Single-Walled Carbon Nanotubes (SWCNT) for a wide range of applications.
From wet chemistry to computer simulations, this year's Materials Processing Center-Center for Materials Science and Engineering Summer Scholars are engaged in MIT research projects targeting stronger materials, more efficient drug delivery, and catalysts for biofuel production.
Xilinx, Inc. today announced Vivado® Design Suite early access support for the 16nm UltraScale+™ portfolio, including Zynq® UltraScale+ and Kintex® UltraScale+ devices. The Vivado early access release has been co-optimized with the UltraScale+ ASIC-class programmable logic to exploit the full advantages of production UltraScale+ devices, leveraging the complete catalog of SmartCORE™ and LogiCORE™ IP.
Xmark Media the organisers of Photonex 2015, the UK’s showcase photonics conference & exhibition announce the programme and speakers for the meeting on Nano-Spectroscopy and Bio-Imaging. This FREE-to-attend conference will be held on Wednesday & Thursday 14th and 15th October as part of the growing two-day event at the visitor-friendly Ricoh Arena in Coventry.
Researchers have developed an innovative technique that makes it possible to self-organize and customize complicated structures at the nanoscale. This breakthrough was facilitated through an international collaboration headed by IBM and the University of Cambridge. The study paves the way to customize material properties and functionalities for a variety of semiconductor device applications.
By Stuart Milne
22 Jul 2015
University at Buffalo engineers have been awarded an $800,000 grant by the Office of Naval Research to create narrow strips of graphene called nanoribbons, which can be a probable solution for how power can be controlled in ships, smartphones and other electronic gadgets.
By Stuart Milne
21 Jul 2015
Nanotechnology is a growing interdisciplinary technology that is often seen as a new industrial revolution. Nanotechnology is increasingly attracting worldwide attention owing to its wide range of end-uses. As nanotechnology is evolving, so is the scope for its commercial expansion.
NanoLock Ltd. entered this week into a license agreement with Hadasit Medical Research Services & Development Ltd. (Jerusalem, Israel), Hadassah Ein-Kerem Medical Center Jerusalem, and Yissum Research Development Com...
DNA, the molecular foundation of life, has new tricks up its sleeve. The four bases from which it is composed snap together like jigsaw pieces and can be artificially manipulated to construct endlessly varied forms in two and three dimensions. The technique, known as DNA origami, promises to bring futuristic microelectronics and biomedical innovations to market.
RNA is a fundamental ingredient in all known forms of life -- so when RNA goes awry, a lot can go wrong. RNA misregulation plays a critical role in the development of many disorders, such as mental disability, autism and cancer.